ClinicalTrials.gov
public full text
Public Domain
Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
The study will compare durations of diarrhea among subjects who report to clinic for treatment and who receive either: 1. standard rifaximin therapy at a dose of 200 mg three times a day for 3 days, OR 2. a single 600 mg dose of rifaximin daily for 3 days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study#826879
- Induction of Clinical Response Using Rifaximin in Crohn's Disease#1075107
- Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders#838058
- The Effects of Rifaximin Therapy in Irritable Bowel Syndrome#1096268
- Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease#838580
Record · ID 866539
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive